(Total Views: 201)
Posted On: 07/24/2023 8:45:47 AM
Post# of 194

$ABBV News Article - AbbVie Advances Immunology Pipeline with First Patient Dosed in Global Phase 3 Trial of Upadacitinib (RINVOQ ) in Hidradenitis Suppurativa https://marketwirenews.com/news-releases/abbv...88029.html


My Twitter: WhyteStocks